Latest news

Search
Categories
News archive

Nanologicas delårsrapport jan-sep 2021

29 October, 2021

FINANSIELL SAMMANFATTNING Nettoomsättningen för tredje kvartalet uppgick till 2 119 TSEK (2 089) och för niomånadersperioden till 12 238 TSEK (10 064) Rörelseresultatet för kvartalet uppgick till -11 718 TSEK (-5 795) och för niomånadersperioden till -26 581 TSEK (-15 924) Resultatet efter skatt för kvartalet uppgick till -12 546 TSEK (-5 899) och för niomånadersperioden till -29 607 TSEK (-16 772) Resultat per aktie före och efter utspädning var -0,45 SEK (-0,21) för kvartalet och

Read more »

Nanologica to Exhibit on BCEIA

17 September, 2021

Nanologica will exhibit on BCEIA (Beijing Conference and Exhibition an Instrumental Analysis) held in Beijing Sep 27-29. BCEIA is a world exposition on analytical science and biochemical technology that attracted more than 25,000 registered participants in 2017.

Read more »

Exercise of Rights in Nanologica’s Stock Option Program

30 June, 2021

In Nanologica’s stock option program 2018/21 exercise of rights in Nanologica’s stock option program has increased the number of shares in the company by 371,346 to 28,165,826 shares. As a result, the share capital increases to SEK 11,548,761. At Nanologica’s Annual General Meeting on May 31, 2018, it was resolved to establish an incentive program of a maximum of 484,883 stock options for the company’s employees. Each option entitles the holder to subscribe for one

Read more »

Redeye Growth Day 2021

31 May, 2021

Nanologica participates at Redeye Growth Day 2021, a live broadcasted event including over 70 Nordic growth companies in the Tech and Life Science sectors. CEO Andreas Bhagwani will present at 13.00. Follow this link to sign up for the event.

Read more »